19 03, 2018

CORRECTION: CVR Medical Announces Temporary Warrant Exercise Price Amendment – Company To Host Conference Call

By | March 19th, 2018|Press Release|0 Comments

VANCOUVER, BC / March 19, 2018 / CVR Medical Corp. The press release that follows is re-issued due to a typographical error in the access code of the original release (issued on March 16, 2018 at 5:30 a.m. PST) whereby access code to the conference call scheduled for March 19, 2018 at 1:00 p.m. EST [...]

16 03, 2018

CVR Medical Announces Temporary Warrant Exercise Price Amendment – Company To Host Conference Call

By | March 16th, 2018|Press Release|0 Comments

VANCOUVER, BC / March 16, 2018 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the "2017 Warrants") from CAD $0.70 (the "Original Exercise Price") to CAD $0.40 [...]

7 03, 2018

Second Trial Data Report: Clinical Substantiation for CVR Medical

By | March 7th, 2018|Press Release|0 Comments

VANCOUVER, BC / March 7, 2018 / CVR Medical Corp. (TSX.V: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical”) advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data collected from tertiary clinical trials for the Carotid Stenotic Scan (CSS) device. His report confirms the evaluation stated in the [...]